Nephrocare Health Services Ltd
company logo

Nephrocare Health Services Ltd

NEPHROPLUS Share Price

BSE:544647

NSE:NEPHROPLUS

673.1

-4.80 (-0.71%)

As on July 24, 2026 at 04:14 PM
Loading chart...

Performance

Loading performance...

677.90

677.90

87056

5.86

2

Fundamentals

6,772.15Cr

90.40

6.07

0.20

7.45

0%

111.03

About

Nephrocare Health Services Limited was incorporated as 'Nephrocare Health Services Private Limited', a private limited company at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh on December 18, 2009. Company was converted into a public limited company and the name was changed to 'Nephrocare Health Services Limited' with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre. The Company set out to address critical gaps in dialysis care through better access, higher clinical standards and a patient-first approach. It provides comprehensive dialysis care through a network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. The Company the business in 2010 with the launch of its first dialysis clinic in Hyderabad. It launched first Public Private Partnership (PPP) clinic in Sananth Nagar, Hyderabad in 2012; acquired 100% stake in DaVita Care (India) Private Limited, the Indian arm of DaVita Care Pte Ltd. in 2018; launched operations in Philippines by acquiring Royal Care Dialysis Center, Inc in 2020. The Company acquired 6 clinics dialysis network with 35000 annual tretaments in 2023 . Further, it has acquired a chain of 7 clinics dialysis network such as AIZ Hemodialysis Center Inc., Bioregen Hemo Center Inc., Carmona Dialysis System Inc., Infini Care Health Systems Inc., and Kolff Dialysis Inc. in FY25. Company came up with the IPO by issuing 18,943,264 Equity Shares having the face value of Rs 2 each and raised funds aggregating to Rs 871.04 crore, comprising a fresh issue of 7,690,162 Equity Shares amounting to Rs 353.4 crore and the offer for sale of 11,253,102 Equity shares amounting to Rs 517.64 crore on December 12, 2025. During FY 2026, Company built an integrated technology ecosystem that connects patients, clinicians, operations, and enterprise functions through cloud computing, artificial intelligence, automation, and data-driven insights. It further expanded the AI platform patient engagement, clinical workflows, operations, and business functions to scale the operations. The Company served 1400+ guests across 6 clinics in 2026. .

Vikram Vuppala

2009

NEPHROPLUS

NameDesignation
Vikram VuppalaChairman & Managing Director
Vishal Vijay GuptaNon Executive Director / Nominee
Gaurav SharmaNon Executive Director / Nominee
SUNIL KUMAR THAKURNon Executive Director / Nominee
Om Prakash ManchandaIndependent Director
HEMANT SULTANIAIndependent Director
Annette Bent Ingrid KumlienIndependent Director
Ajay BaksliiIndependent Director
Kishore KathriCompany Sec. & Compli. Officer

Nephrocare Health Services Ltd FAQs

How do I Buy Nephrocare Health Services Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Nephrocare Health Services Ltd shares in BlinkX.

What is the Share Price of Nephrocare Health Services Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Nephrocare Health Services Ltd's share price is ₹673.1 as of 2026-07-24.

What is the PE ratio of Nephrocare Health Services Ltd?

close

Nephrocare Health Services Ltd's P/E ratio is 90.4 times as of 2026-07-24.

What is the PB ratio of Nephrocare Health Services Ltd?

close

Nephrocare Health Services Ltd's most recent financial reports indicate a price-to-book ratio of 6.07, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Nephrocare Health Services Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Nephrocare Health Services Ltd's market capitalization is ₹6772.15 Cr as on 2026-07-24.

What is the ROE of Nephrocare Health Services Ltd?

close

The current financial records of Nephrocare Health Services Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Nephrocare Health Services Ltd?

close

According to Nephrocare Health Services Ltd's most recent financial filings, the company has a total asset value of ₹501.86, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Nephrocare Health Services Ltd?

close

The 52-week high/low price of a Nephrocare Health Services Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Nephrocare Health Services Ltd's 52-week high and low as of 2026-07-24 are ₹769.75 and ₹446, respectively.